Microelectrode arrays are also known as multi-electrode arrays. Microelectrode arrays are devices, which have many (tens to thousands) shanks or plates also known as micro-electrodes. Neural signals are delivered by connecting neurons to electronic circuitry. Non-implantable microelectrode arrays are used in in vitro microelectrode arrays and implantable are used in in vivo microelectrode arrays.
Highlights
The global In Vitro and In Vivo Microelectrode Array market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for In Vitro and In Vivo Microelectrode Array is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for In Vitro and In Vivo Microelectrode Array is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for In Vitro and In Vivo Microelectrode Array in Pharmaceutical and Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of In Vitro and In Vivo Microelectrode Array include Tucker Davis Technologies, Screen Holdings Co. Ltd., Plexon, Inc., Neuronexus, Neuralynx, Inc., MaxWell Biosystems AG, Harvard Bioscience, Inc., Blackrock Microsystems LLC and Axion BioSystems, Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In Vitro and In Vivo Microelectrode Array, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro and In Vivo Microelectrode Array.
The In Vitro and In Vivo Microelectrode Array market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In Vitro and In Vivo Microelectrode Array market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro and In Vivo Microelectrode Array companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Tucker Davis Technologies
Screen Holdings Co. Ltd.
Plexon, Inc.
Neuronexus
Neuralynx, Inc.
MaxWell Biosystems AG
Harvard Bioscience, Inc.
Blackrock Microsystems LLC
Axion BioSystems, Inc.
3Brain AG
Segment by Type
Multiwell Microelectrode Array
Single Well Microelectrode Array
Segment by Application
Pharmaceutical and Biotechnology Companies
Academics and Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro and In Vivo Microelectrode Array companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro and In Vivo Microelectrode Array Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Multiwell Microelectrode Array
1.2.3 Single Well Microelectrode Array
1.3 Market by Application
1.3.1 Global In Vitro and In Vivo Microelectrode Array Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Academics and Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro and In Vivo Microelectrode Array Market Perspective (2018-2029)
2.2 In Vitro and In Vivo Microelectrode Array Growth Trends by Region
2.2.1 Global In Vitro and In Vivo Microelectrode Array Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 In Vitro and In Vivo Microelectrode Array Historic Market Size by Region (2018-2023)
2.2.3 In Vitro and In Vivo Microelectrode Array Forecasted Market Size by Region (2024-2029)
2.3 In Vitro and In Vivo Microelectrode Array Market Dynamics
2.3.1 In Vitro and In Vivo Microelectrode Array Industry Trends
2.3.2 In Vitro and In Vivo Microelectrode Array Market Drivers
2.3.3 In Vitro and In Vivo Microelectrode Array Market Challenges
2.3.4 In Vitro and In Vivo Microelectrode Array Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro and In Vivo Microelectrode Array Players by Revenue
3.1.1 Global Top In Vitro and In Vivo Microelectrode Array Players by Revenue (2018-2023)
3.1.2 Global In Vitro and In Vivo Microelectrode Array Revenue Market Share by Players (2018-2023)
3.2 Global In Vitro and In Vivo Microelectrode Array Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro and In Vivo Microelectrode Array Revenue
3.4 Global In Vitro and In Vivo Microelectrode Array Market Concentration Ratio
3.4.1 Global In Vitro and In Vivo Microelectrode Array Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro and In Vivo Microelectrode Array Revenue in 2022
3.5 In Vitro and In Vivo Microelectrode Array Key Players Head office and Area Served
3.6 Key Players In Vitro and In Vivo Microelectrode Array Product Solution and Service
3.7 Date of Enter into In Vitro and In Vivo Microelectrode Array Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro and In Vivo Microelectrode Array Breakdown Data by Type
4.1 Global In Vitro and In Vivo Microelectrode Array Historic Market Size by Type (2018-2023)
4.2 Global In Vitro and In Vivo Microelectrode Array Forecasted Market Size by Type (2024-2029)
5 In Vitro and In Vivo Microelectrode Array Breakdown Data by Application
5.1 Global In Vitro and In Vivo Microelectrode Array Historic Market Size by Application (2018-2023)
5.2 Global In Vitro and In Vivo Microelectrode Array Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America In Vitro and In Vivo Microelectrode Array Market Size (2018-2029)
6.2 North America In Vitro and In Vivo Microelectrode Array Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America In Vitro and In Vivo Microelectrode Array Market Size by Country (2018-2023)
6.4 North America In Vitro and In Vivo Microelectrode Array Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro and In Vivo Microelectrode Array Market Size (2018-2029)
7.2 Europe In Vitro and In Vivo Microelectrode Array Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe In Vitro and In Vivo Microelectrode Array Market Size by Country (2018-2023)
7.4 Europe In Vitro and In Vivo Microelectrode Array Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro and In Vivo Microelectrode Array Market Size (2018-2029)
8.2 Asia-Pacific In Vitro and In Vivo Microelectrode Array Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific In Vitro and In Vivo Microelectrode Array Market Size by Region (2018-2023)
8.4 Asia-Pacific In Vitro and In Vivo Microelectrode Array Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro and In Vivo Microelectrode Array Market Size (2018-2029)
9.2 Latin America In Vitro and In Vivo Microelectrode Array Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America In Vitro and In Vivo Microelectrode Array Market Size by Country (2018-2023)
9.4 Latin America In Vitro and In Vivo Microelectrode Array Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro and In Vivo Microelectrode Array Market Size (2018-2029)
10.2 Middle East & Africa In Vitro and In Vivo Microelectrode Array Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa In Vitro and In Vivo Microelectrode Array Market Size by Country (2018-2023)
10.4 Middle East & Africa In Vitro and In Vivo Microelectrode Array Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Tucker Davis Technologies
11.1.1 Tucker Davis Technologies Company Detail
11.1.2 Tucker Davis Technologies Business Overview
11.1.3 Tucker Davis Technologies In Vitro and In Vivo Microelectrode Array Introduction
11.1.4 Tucker Davis Technologies Revenue in In Vitro and In Vivo Microelectrode Array Business (2018-2023)
11.1.5 Tucker Davis Technologies Recent Development
11.2 Screen Holdings Co. Ltd.
11.2.1 Screen Holdings Co. Ltd. Company Detail
11.2.2 Screen Holdings Co. Ltd. Business Overview
11.2.3 Screen Holdings Co. Ltd. In Vitro and In Vivo Microelectrode Array Introduction
11.2.4 Screen Holdings Co. Ltd. Revenue in In Vitro and In Vivo Microelectrode Array Business (2018-2023)
11.2.5 Screen Holdings Co. Ltd. Recent Development
11.3 Plexon, Inc.
11.3.1 Plexon, Inc. Company Detail
11.3.2 Plexon, Inc. Business Overview
11.3.3 Plexon, Inc. In Vitro and In Vivo Microelectrode Array Introduction
11.3.4 Plexon, Inc. Revenue in In Vitro and In Vivo Microelectrode Array Business (2018-2023)
11.3.5 Plexon, Inc. Recent Development
11.4 Neuronexus
11.4.1 Neuronexus Company Detail
11.4.2 Neuronexus Business Overview
11.4.3 Neuronexus In Vitro and In Vivo Microelectrode Array Introduction
11.4.4 Neuronexus Revenue in In Vitro and In Vivo Microelectrode Array Business (2018-2023)
11.4.5 Neuronexus Recent Development
11.5 Neuralynx, Inc.
11.5.1 Neuralynx, Inc. Company Detail
11.5.2 Neuralynx, Inc. Business Overview
11.5.3 Neuralynx, Inc. In Vitro and In Vivo Microelectrode Array Introduction
11.5.4 Neuralynx, Inc. Revenue in In Vitro and In Vivo Microelectrode Array Business (2018-2023)
11.5.5 Neuralynx, Inc. Recent Development
11.6 MaxWell Biosystems AG
11.6.1 MaxWell Biosystems AG Company Detail
11.6.2 MaxWell Biosystems AG Business Overview
11.6.3 MaxWell Biosystems AG In Vitro and In Vivo Microelectrode Array Introduction
11.6.4 MaxWell Biosystems AG Revenue in In Vitro and In Vivo Microelectrode Array Business (2018-2023)
11.6.5 MaxWell Biosystems AG Recent Development
11.7 Harvard Bioscience, Inc.
11.7.1 Harvard Bioscience, Inc. Company Detail
11.7.2 Harvard Bioscience, Inc. Business Overview
11.7.3 Harvard Bioscience, Inc. In Vitro and In Vivo Microelectrode Array Introduction
11.7.4 Harvard Bioscience, Inc. Revenue in In Vitro and In Vivo Microelectrode Array Business (2018-2023)
11.7.5 Harvard Bioscience, Inc. Recent Development
11.8 Blackrock Microsystems LLC
11.8.1 Blackrock Microsystems LLC Company Detail
11.8.2 Blackrock Microsystems LLC Business Overview
11.8.3 Blackrock Microsystems LLC In Vitro and In Vivo Microelectrode Array Introduction
11.8.4 Blackrock Microsystems LLC Revenue in In Vitro and In Vivo Microelectrode Array Business (2018-2023)
11.8.5 Blackrock Microsystems LLC Recent Development
11.9 Axion BioSystems, Inc.
11.9.1 Axion BioSystems, Inc. Company Detail
11.9.2 Axion BioSystems, Inc. Business Overview
11.9.3 Axion BioSystems, Inc. In Vitro and In Vivo Microelectrode Array Introduction
11.9.4 Axion BioSystems, Inc. Revenue in In Vitro and In Vivo Microelectrode Array Business (2018-2023)
11.9.5 Axion BioSystems, Inc. Recent Development
11.10 3Brain AG
11.10.1 3Brain AG Company Detail
11.10.2 3Brain AG Business Overview
11.10.3 3Brain AG In Vitro and In Vivo Microelectrode Array Introduction
11.10.4 3Brain AG Revenue in In Vitro and In Vivo Microelectrode Array Business (2018-2023)
11.10.5 3Brain AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Tucker Davis Technologies
Screen Holdings Co. Ltd.
Plexon, Inc.
Neuronexus
Neuralynx, Inc.
MaxWell Biosystems AG
Harvard Bioscience, Inc.
Blackrock Microsystems LLC
Axion BioSystems, Inc.
3Brain AG
听
听
*If Applicable.
